The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) is a National Cancer Institute-designated cancer center. We maintain an interactive, multidisciplinary research program -- consisting of both clinical and basic research investigators -- focusing on the rapid transfer of knowledge from the laboratory to the clinic. Our goal is to take advantage of discoveries in basic cancer biology in conjunction with clinical research to:
- Develop and apply innovative cancer treatment and prevention strategies
- Describe the molecular mechanisms underlying specific clinical phenotypes and behaviors
- Apply these discoveries and strategies to the Maryland community and beyond, with a specific focus on cancer disparities
Comprehensive Research Programs:
Our research is conducted in several laboratories at the University of Maryland Medical School and within the cancer center's laboratories and clinics in the University of Maryland Medical Center.
More News »
Several Shared Services provide support and facilitate specialized research activities for all UMGCC investigators.
See our Clinical Investigator Handbook (PDF).
UMGCC is currently conducting more than 200 clinical trials. Search our database of clinical trials by disease site, treatment type, investigator or study number for information.
University of Maryland Marlene and Stewart Greenebaum Cancer Center
Research Administration, N9E17
22 S. Greene Street
Baltimore, Maryland 21201
This page was last updated: April 8, 2015